Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;14(6):1277-1282.
doi: 10.3233/JPD-240088.

Unmet Need in Early-Onset Parkinson's Disease: Deep Brain Stimulation and Pregnancy

Affiliations
Review

Unmet Need in Early-Onset Parkinson's Disease: Deep Brain Stimulation and Pregnancy

Katarzyna Smilowska et al. J Parkinsons Dis. 2024.

Abstract

Pregnancy in women with early-onset Parkinson's disease (PD) is likely to have a higher frequency given the trend toward increasing maternal age, thus resulting in a greater overlap time between childbearing age and PD risk. Deep brain stimulation (DBS) therapy is nowadays offered to PD patients at earlier stage of the disease, when women can still be pre-menopausal. However, few data are available about DBS safety during pregnancy. From a review of the available literature, only one article was published on this topic so far. Therefore, we have developed a clinical consensus on the safety of DBS during pregnancy in PD patients.

Keywords: Parkinson’s disease; deep brain stimulation; pregnancy.

PubMed Disclaimer

Conflict of interest statement

R. Savica, R.N. Alcalay, and E.-K. Tan are Editorial Board members of this journal, but were not involved in the peer-review process of this article nor had access to any information regarding its peer review.

R. Mehanna is on the speaker bureau for TEVA and Kyowa Kirin. He has received research grants from, Global Kinetic Corporation, Northera, Neurocrine, and Cerevel.

J.E. Fleisher reports royalties from UpToDate, Inc; honoraria from Parkinson’s Foundation & Davis Phinney Foundation, and research support from NIH, Parkinson’s Foundation, and CurePSP.

R.N. Alcalay reports consultation fees from Avrobio, Caraway, GSK, Merck, Ono Therapeutics, and Sanofi; and research support from NIH, DoD, the Parkinson’s Foundation, and The Michael. J. Fox Foundation. RN institution (TLVMC) is supported by Biogen.

K.R. Kumar received honoraria from Seqirus, Abbvie, Research Review Australia, The International Parkinson and Movement Disorder Society (MDS), and grant funding from the Paul Ainsworth Family Foundation and the Medical Research Future Fund.

C. Marras reports research support from the Michael J Fox Foundation, the Parkinson’s Foundation and the Canadian Institutes of Health Research.

O.A. Ross reports research support from NIH, DoD, the Parkinson’s, The Michael. J. Fox Foundation and American Brain Foundation.

V. Fraix reports consultancies for Abbott, Medtronic, and Kyowa and major grants from Medtronic and Ipsen. She received payment for lectures from Abbott and Medtronic.

E. Moro reports consultancies for Abbott, Medtronic, and Kyowa and major grants from Medtronic and Ipsen. She received payment for lectures from Abbott and Medtronic.

E.-K. Tan received honoraria for editorial duties for Clinical Parkinsonism Related Disorders and grant support from the National Medical Research Council, Singapore.

R. Savica received research support from the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, and the Mayo Clinic Small Grants Program

National Center for Advancing Translational Sciences (NCATS) and an unrestricted research grant from Acadia Pharmaceuticals, Inc.

All other authors have no conflict of interest to report.

References

    1. Mocking RJT, Graat I, Denys D (2021) Why has deep brain stimulation had so little impact in psychiatry? Front Neurol 12, 757142. - PMC - PubMed
    1. Deuschl G, Antonini A, Costa J, Śmiłowska K, Berg D, Corvol JC, Fabbrini G, Ferreira J, Foltynie T, Mir P, Schrag A, Seppi K, Taba P, Ruzicka E, Selikhova M, Henschke N, Villanueva G, Moro E (2022) European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson’s Disease: I. Invasive Therapies. Mov Disord 37, 1360–1374. - PubMed
    1. Deuschl G, Antonini A, Costa J, Śmiłowska K, Berg D, Corvol JC, Fabbrini G, Ferreira J, Foltynie T, Mir P, Schrag A, Seppi K, Taba P, Ruzicka E, Selikhova M, Henschke N, Villanueva G, Moro E (2022) European Academy of Neurology/Movement Disorder Society – European Section guideline on the treatment of Parkinson’s disease: I. Invasive therapies. Eur J Neurol 29, 2580–2595. - PubMed
    1. Mehanna R, Smilowska K, Fleisher J, Post B, Hatano T, Pimentel Piemonte ME, Kumar KR, McConvey V, Zhang B, Tan EK, Savica R (2022) Age cutoff for early-onset Parkinson’s disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson’s Disease. Mov Disord Clin Pract 9, 869–878. - PMC - PubMed
    1. Camerucci E, Stang CD, Hajeb M, Turcano P, Mullan AF, Martin P, Ross OA, Bower JH, Mielke MM, Savica R (2021) Early-onset parkinsonism and early-onset Parkinson’s disease: A population-based study (2010– 2015). J Parkinsons Dis 11, 1197–1207. - PMC - PubMed

Publication types

Grants and funding

LinkOut - more resources